Autopsy report · NCT00311311
Study Comparing Effect On Carotid Atherosclerosis Following Conversion From Tacrolimus To Sirolimus Post-Transplant In Kidney Transplant Patients
Cause of deathNo reason given
“See termination reason in detailed description.”
Life of this trial
- Ran for about 5 years 9 months before it stopped.
- 72 participants enrolled.
- Results were posted on the registry 4 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- Pfizer
- Sponsor type
- Industry
- Conditions
- Atherosclerosis; Kidney Failure
- Interventions
- tacrolimus; mycophenolate mofetil; prednisone; sirolimus; tacrolimus; mycophenolate mofetil
- Participants
- 72
- Sites
- 8
- Countries
- Canada, United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.